We are live on
!
Find out more
Vanguard Fiduciary Trust Portfolio holdings
AUM
$454B
This Fund
S&P 500
This Quarter
Est. Return
+25.89%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$454B
AUM Growth
+$58.2B
(+15%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
0.24%
Top 10 Holdings %
Top 10 Hldgs %
29.47%
Holding
4,173
New
110
Increased
2,642
Reduced
1,032
Closed
97
Avg Time Held
1
quarter
Top 10 Avg Time Held
0.9
quarters
Top 20 Avg Time Held
0.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$644M |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$393M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$173M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$170M |
| 5 |
SUNB
Sunbelt Rentals Holdings
SUNB
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$401M |
| 2 |
Apple
AAPL
|
+$206M |
| 3 |
Microsoft
MSFT
|
+$175M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.13% |
| 2 | Financials | 13.36% |
| 3 | Industrials | 10.07% |
| 4 | Healthcare | 9.55% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3951
Roadzen
RDZN
$104M
| $27.9K | ﹤0.01% |
+19,077
| New | +$30.3K |
2026 Q2
0 quarters
|
|
3952
Cadrenal Therapeutics
CVKD
$3.35M
| $27.8K | ﹤0.01% |
8,311
| – | – |
2026 Q1
1 quarter
|
|
3953
Cemtrex
CETX
$3.51M
| $27.7K | ﹤0.01% |
+9,120
| New | +$74.7K |
2026 Q2
0 quarters
|
|
3954
Ainos
AIMD
$9.97M
| $27.5K | ﹤0.01% |
14,169
| – | – |
2026 Q1
1 quarter
|
|
3955
Oxbridge Re Holdings
OXBR
$9.12M
| $27.4K | ﹤0.01% |
26,649
| – | – |
2026 Q1
1 quarter
|
|
3956
Exicure
XCUR
$7.53M
| $27.4K | ﹤0.01% |
13,161
| – | – |
2026 Q1
1 quarter
|
|
|
IHT
3957
InnSuites Hospitality Trust
IHT
$14.8M
| $27.4K | ﹤0.01% |
16,092
| – | – |
2026 Q1
1 quarter
|
|
3958
Rocky Mountain Chocolate Factory
RMCF
$8.35M
| $27.2K | ﹤0.01% |
30,507
| – | – |
2026 Q1
1 quarter
|
|
|
CNTB
3959
Connect Biopharma Holdings
CNTB
$58.4M
| $26.9K | ﹤0.01% |
+11,314
| New | +$27.4K |
2026 Q2
0 quarters
|
|
|
HIND
3960
Vyome Holdings
HIND
$13.4M
| $26.2K | ﹤0.01% |
12,195
| – | – |
2026 Q1
1 quarter
|
|
3961
NextCure
NXTC
$23.3M
| $25.8K | ﹤0.01% |
16,134
+119
| +0.7% | +$880 |
2026 Q1
1 quarter
|
|
|
TWAV
3962
TaoWeave Inc
TWAV
$6.09M
| $25.5K | ﹤0.01% |
18,472
| – | – |
2026 Q1
1 quarter
|
|
3963
Local Bounti
LOCL
$25.5M
| $25.4K | ﹤0.01% |
19,664
| – | – |
2026 Q1
1 quarter
|
|
3964
bioAffinity Technologies
BIAF
$3.63M
| $25.2K | ﹤0.01% |
2,071
| – | – |
2026 Q1
1 quarter
|
|
3965
Alzamend Neuro
ALZN
$6.61M
| $25.2K | ﹤0.01% |
21,020
| – | – |
2026 Q1
1 quarter
|
|
3966
Cocrystal Pharma
COCP
$22.2M
| $25.2K | ﹤0.01% |
24,016
| – | – |
2026 Q1
1 quarter
|
|
3967
Acurx Pharmaceuticals
ACXP
$5.46M
| $25.1K | ﹤0.01% |
16,205
| – | – |
2026 Q1
1 quarter
|
|
3968
Pulmatrix
PULM
$5.73M
| $25K | ﹤0.01% |
14,715
| – | – |
2026 Q1
1 quarter
|
|
|
ORGN
3969
DELISTED
Origin Materials
ORGN
| $25K | ﹤0.01% |
25,251
-3,653
| -13% | -$5.95K |
2026 Q1
1 quarter
|
|
|
KRSA
3970
Korsana Biosciences, Inc. Common Stock
KRSA
$1.39B
| $24.9K | ﹤0.01% |
1,050
| – | – |
2026 Q1
1 quarter
|
|
3971
Moving iMage Technologies
MITQ
$5.75M
| $24.8K | ﹤0.01% |
42,755
| – | – |
2026 Q1
1 quarter
|
|
|
KAPA
3972
Kairos Pharma
KAPA
$5.28M
| $24.5K | ﹤0.01% |
9,126
| – | – |
2026 Q1
1 quarter
|
|
|
AIFA
3973
All In FutureTech Alliance Inc
AIFA
$28.7M
| $24.5K | ﹤0.01% |
10,971
-1
| -0% | -$3 |
2026 Q1
1 quarter
|
|
3974
XWELL
XWEL
$7.2M
| $24.3K | ﹤0.01% |
23,380
| – | – |
2026 Q1
1 quarter
|
|
3975
Expion Energy, Inc. Common Stock
XPON
$4M
| $24K | ﹤0.01% |
4,447
| – | – |
2026 Q1
1 quarter
|
|
Similar funds
Vanguard Fiduciary Trust's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Fiduciary Trust held 4,173 positions worth $454B, up 15% from $396B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q2 2026: portfolio turnover was 5%. Vanguard Fiduciary Trust opened 110 new positions and exited 97, leaving the 4,173-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.
- Vanguard Fiduciary Trust's largest Q2 2026 buy was SpaceX: 3,791,999 shares worth $648M.
- Vanguard Fiduciary Trust added most to Alphabet (Google) Class A in Q2 2026, an estimated $173M increase.
- Vanguard Fiduciary Trust's biggest Q2 2026 reduction was Honeywell, cutting an estimated $401M.
- Vanguard Fiduciary Trust fully exited Coterra Energy in Q2 2026, selling an estimated $149M.
- Vanguard Fiduciary Trust's ten largest holdings make up 29% of its $454B portfolio in Q2 2026.
- Vanguard Fiduciary Trust opened 110 new positions and closed 97 in Q2 2026.
- Vanguard Fiduciary Trust's portfolio value rose 15% quarter-over-quarter to $454B.
Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.